Close
Almac
Achema middle east

Press Releases

First International Laboratory near Geneva, Switzerland to Support Clinical Trials opening announced by NeoGenomics

NeoGenomics, Inc. , a leading provider of cancer-focused genetic testing services in the United States, announced that it has opened its first international laboratory facility in Rolle, Switzerland, in the Canton of Vaud, just outside of Geneva as a...

Frost & Sullivan Award for Customer Service Leadership in Bioanalytical Contract Testing won by Sartorius Stedim Biotech

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, received the prestigious Frost & Sullivan’s 2017 European Customer Service Leadership Award for Bioanalytical Contract Testing Services. Presented at the Frost & Sullivan ceremony yesterday evening in London,...

CorFlow Completes the First Close of the Seed+ Financing Round

CorFlow Therapeutics AG announced that the company has completed the CHF 2.6M 1st close of its Seed+ financing round led by experienced private medical device investors who over the last decades have supported breakthrough interventional cardiology technologies. ...

Biogen and Eisai Expand Existing Collaboration Agreement to Develop and Commercialize Investigational Alzheimer’s Disease

Eisai Co., Ltd. and Biogen Inc. announced today that the companies have expanded their existing agreement to jointly develop and commercialize investigational Alzheimer's disease treatments. Under the terms of the agreement Eisai has exercised its option...

Nanobiotix Completes Patient Inclusion for Phase II/III Trial of NBTXR3 in Soft Tissue Sarcoma

NANOBIOTIX , a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, announced that it has completed patient inclusion for the Phase II/III trial (Act.In.Sarc) of its lead product candidate, NBTXR3, in soft tissue sarcoma. ...

KalVista Pharmaceuticals Announces Collaboration with Merck

KalVista Pharmaceuticals, Inc , a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors announced that it has entered into a collaboration agreement with Merck, known as MSD outside the United States...

EAHP Congress – register as a participant and submit your abstract

Gothenburg in Sweden, a beautiful city with an exciting cultural life will be the destination of the 23rd Congress of the European Association of Hospital Pharmacists (EAHP). Hospital pharmacists from all over the world will be...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »